Evidence map›Paper›PMID 42059612›Full record

ArticleJournal of clinical microbiology2026

Diagnostic value of galactomannan in tracheobronchial aspirate for

Arnau Monforte, Maria Teresa Martín-Gómez, Cristina Berastegui, Ester Márquez-Algaba, Judith Sacanell, Joel Rosado, Anna Falcó-Roget, Gonzalo Escudero, Jose Casanovas, Cristina Kirkegaard-Biosca and 5 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Arnau MonforteInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-5468-3885
Maria Teresa Martín-GómezMicrobiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-8119-8749
Cristina BerasteguiPneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-9774-9349
Ester Márquez-AlgabaInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Judith SacanellIntensive Care Department, Hospital Universitari Vall d'Hebron, SODIR Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Joel RosadoThoracic Surgery Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Anna Falcó-RogetInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0009-0003-1774-679X
Gonzalo EscuderoInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-7265-3516
Jose CasanovasInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Cristina Kirkegaard-BioscaInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-9035-1450
Berta Sáez-GiménezPneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-9307-728X
Víctor MonfortePneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-2918-7679
Joan GavaldàInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Oscar Len *Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ibai Los-Arcos *Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-8835-2702

Funding

Merck & Co. | MSD Sharp and Dohme (MSD) PR(AG)54-2020
6 · The paper itself

Abstract

Lung transplant recipients (LTR) are highly susceptible to

Indexed as

AspergillosisBronchoalveolar Lavage FluidLung TransplantationMannansTransplant RecipientsAdultAgedAspergillusBronchoscopyFemaleGalactoseHumansMaleMiddle AgedRetrospective StudiesROC CurvegalactomannanGalactoseMannansfungal biomarkersfungal infectioninvasive aspergillosislung transplantationpulmonary aspergillosis

Identifiers

PMID42059612
PMCPMC13251414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.